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Evidence for IgA-specific B cell hyperactivity in patients with IgA
nephropathy. Spontaneous in vitro IgA synthesis by peripheral blood
mononuclear cells (PBMC) of patients with IgA nephropathy was
elevated; 419 71 ng/l06 cells (Mean saM) compared with controls;
217 35 (P < 0.02). Pokeweed mitogen (PWM) stimulated IgA
synthesis was also elevated in patients; 4326 1140 ng/106 cells (Mean
5EM) versus 1458 406 (P < 0.02) but the PWM stimulation index for
patients did not differ significantly from that of the controls.
Concanavalin A (Con A) suppression of PWM stimulated IgA synthesis
resulted in the generation of similar quantities of IgA by PBMC from
both patients and controls but the percentage suppression was signifi-
cantly elevated in patients; 87 5 (Mean SCM) versus 58 10 (P C
0.05). Synthesis of igu and 1gM followed the same pattern as that
described for IgA. T and B cells from patients and controls were
cultured alone and in various co-culture permutations. Enriched B cells
of patients demonstrated a selectively increased capacity for IgA
production; 266 106 ag/S x l0 cells (Mean 5EM) compared with
controls; 42 9 (P c 0.01) and this parameter correlated significantly
with serum IgA concentrations (R = 0.77, P c 0.05). Overall analysis of
co-culture data showed no significant difference between the influences
of autologous, control or patient T cells on immunoglobulin synthesis
by normal B cells. Autolymphocytotoxic antibodies were not detected
and, compared with controls, patient sera had no differential effect on
numbers of igA producing cells generated in culture. Longitudinal
studies in four patients showed no consistent relationship between in
vitro IgA synthesis and clinical evidence of disease activity, and no
abnormalities of IgA synthesis were observed in nine first degree
relatives of patients.
The finding of elevated serum IgA concentrations in patients
with IgA nephropathy [1—3] has prompted a number of re-
searchers to investigate various aspects of immunoregulation in
these patients, but controversy has arisen with some authors
reporting increased in vitro IgA production by unstimulated
peripheral blood mononuclear cells (PBMC) 141, others observ-
ing an increase only when PBMC were stimulated with
pokeweed mitogen (PWM) [5], while some found no abnormal-
ity of in vitro immunoglobulin (Ig) synthesis at all 16, 71.
Suggested mechanisms for increased IgA synthesis have
included decreased IgA-specific suppressor T cell activity [8]
and increased IgA-specific helper T cell activity [5]. Other
cellular aberrations have been reported which include: in-
creased numbers of IgA-bearing cells [9] (subsequently refuted
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[10]); increased numbers of T cells with receptors for the Fc
portion of IgA (Ta cells) [11]; increased numbers of Ba cells
[12] and reduced numbers of T8 positive cells leading to
elevated T4/T8 ratios [4, 7, 13].
While there is a considerable body of evidence supporting the
existence of some deregulation of the cellular immune system in
IgA nephropathy, it has not been possible to pinpoint a central
mechanism for the increased IgA synthesis. The present study
confirms the observation [4] of increased IgA synthesis by
unstimulated PBMC from some patients with IgA nephropathy,
and attempts to elucidate the mechanism for this increase by in
vitro cellular studies using unfractionated PBMC and enriched
T and B cell populations.
Included in this report are data from longitudinal studies of in
vitro IgA synthesis in patients, some of whom underwent
clinical exacerbations, data on IgA synthesis in a small number
of first degree relatives of patients and the results of a study to
evaluate the effects of sera from patients with IgA nephropathy
on numbers of IgA producing cells generated in culture.
Methods
Subjects
In vitro Ig synthesis by PBMC was studied in 18 male and
three female patients ranging in age from 16 to 66 years (Mean
41, CD 13.8), and in 21 age/sex matched controls. All the
patients had primary IgA nephropathy as defined by clinical and
renal biopsy criteria [2], i.e., renal immunofluorescence re-
vealed IgA as the predominant Ig in mesangial deposits, and in
no patient was there evidence of systemic disease, e.g.,
Henoch—Schonlein purpura (HSP) or of conditions known to
cause "secondary" IgA nephropathy, e.g., alcoholic liver dis-
ease. Clinical and biological data on the patients are shown in
Table 1. Only one patient had a plasma creatinine concentration
greater than 0.2 mmoles/liter, none was actively hematuric, nor
was any patient receiving phenytoin or other immunosuppres-
sive drugs at the time of the study. The controls were healthy
volunteers with normal urinalyses.
Eight patients were studied on more than one occasion while
clinically quiescent. Four were studied during periods of both
clinical activity (synpharyngitic hematuria) and quiescence.
Repeated tests were also performed on nine control subjects
who were in good health on both occasions. Blood specimens
for these longitudinal studies were obtained between 8.00 and
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Table 1. Clinical and biological data of patients with IgA nephropathy
Patient
no.
Age
yrs Sex
Hyper-
tensiona
(+1—)
Plasma
creatimn&'
mmoles/liter
Serum
IgAc
glliter
Renal biopsy immunofluorescence
score (— to ++ +)
IgA IgG 1gM
1 29 M — 0.09 3.90 ++ — +
2 32 M + 0.10 1.97 ++ + +
3 43 M + 0.17 3.27 ++ — +
4 66 M + 0.13 2.49 + —
5 54 M + 0.41 2.57 + —
6 61 M + 0.14 3.56 +
7 51 M + 0.14 3.29 + —
8 34 F — 0.08 2.90 + —
9 40 M — 0.08 2.99 + —
10 25 M — 0.08 3.23 ++ —
11 57 M + 0.19 2.65 ++
12 40 M + 0.11 1.84 + —
13 55 M + 0.13 1.50 + — —
14 30 F — 0.07 3.29 ++ — —
15 16 F — 0.06 5.96 + —
16 47 M + 0.10 4.52 + — —
17 44 M — 0.10 3.29 ++ — —
18 47 M + 0.13 3.47 ++ — —
19 19 M — 0.09 3.18 + —
20 27 M — 0.07 6.22 + —
21 43 M — 0.12 3.46 ++
a Hypertension, + indicates blood pressure> 140/90.
b Plasma creatinine, normal range is 0.05 to 0.12 mmoles/liter.
c Serum IgA concentrations were determined at the time of the current study. The normal range (mean 2 standard deviations of 21 healthy
volunteers) was 0.18 to 3.42 g/liter.
10.00 a.m. None of the subjects was receiving any medication
known to influence the immune response.
IgA synthesizing activities of PBMC were evaluated in rune first
degree relatives of patients. All were healthy and had normal
urinalyses. They comprised the mother, sister and two brothers of
one patient, the mother and sister of another, the sister of a third
patient and two brothers each of further patients. Their ages
ranged from 14 to 57 years (Mean 33.2, SD 16.5).
Ig synthesis by enriched B cell populations was studied in
eight patients and 11 controls. Fractionated T and B cells from
seven of the patients were used in various co-culture permuta-
tions, with T and B cells isolated from a total of 11 controls.
Sera from five patients were tested to determine their influ-
ence on numbers of IgA—producing cells generated among
PBMC cultured from autologous or control subjects. Two of the
five were also tested with allogeneic patient cells. Sera from ten
control subjects were tested with autologous and allogeneic
control cells and eight of them were tested with patient cells.
Twenty of the patients were tested for serum autolymphocyto-
toxic antibodies and serum IgA concentrations were measured
in all subjects.
Complete culture medium (CCM)
This was comprised of RPMI 1640 (Flow Laboratories,
McLean, Virginia, USA) supplemented with 10% heat inactivated
(56°C for 30 mm) fetal bovine serum (Commonwealth Serum
Laboratories, Melbourne, Victoria, Australia) 2 mat glutarnine, 30
sg/ml penicillin, 20 jg/ml gentamicin and 1 g/ml fungizone.
Mitogens. PWM (Sigma Chemical Co., St. Louis, Missouri,
USA) was used at a final concentration of 1 sg/ml.
Concanavalin A (Con A) (Pharmacia Fine Chemicals, Uppsala,
Sweden) was used at a final concentration of S sg/ml. Prelimi-
nary studies indicated that maximal stimulation of Ig synthesis
by PWM, and maximal Con A suppression of PWM stimulated
Ig synthesis were achieved using these concentrations.
Ig synthesis by PBMC
PBMC were separated from heparinized whole blood by
density gradient centrifugation using Ficoll Paque (Pharmacia
Fine Chemicals). After three washes in Dulbecco's buffer pH
7.4, the cells were resuspended at a concentration of 1 X 106/ml
in CCM. One ml quantities of this cell suspension were dis-
pensed into flat-bottomed plastic vials and cultured in dupli-
cates without mitogens, with PWM, or with PWM and Con A.
Incubation was at 37°C in a humid atmosphere of 5% CO2 in air.
After eight days, culture supernatants were harvested by cen-
trifugation and stored at —70°C until concentrations of IgA, IgG
and 1gM were measured by an ELISA system. Results were
expressed as ng Ig produced/i x 106 PBMC. The PWM
stimulation index was calculated as follows:
PWM stimulated Ig synthesisPWM stimulation index = _________________________
unstimulated Ig synthesis
The percentage suppression by Con A of PWM stimulated Ig
synthesis was calculated as suggested by Miller and Schwartz
[14]:
PWM stim. Ig —
Percentage Con A (PWM & Con A stim. Ig) x 100
suppression — PWM stim. Ig
When PBMC from patients or controls were cultured for
eight days in the presence of 50 sg/ml of the metabolic inhibitor
cyclohexamide, no significant quantities of Ig were detected in
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supernatants. This assured that Ig, where detected in eight day
culture supernatants, resulted from de novo synthesis and not
from carry-over of free or cell-bound Ig, nor from spontaneous
release of Ig by B cells.
ELISA for measurement of Ig concentrations
Ig fractions of rabbit antisera to human IgA, IgG and 1gM
were obtained from Dako-immunoglobulins (Copenhagen, Den-
mark), and used at 1/5000, 1/2000 and 1/5000 dilutions respec-
tively. Microtiter plates (Costar, Cambridge, Massachusetts,
USA) were coated by adding 100 gil/well of the appropriate
antiserum diluted in 0.015M sodium carbonate-bicarbonate
buffer pH 9.6. Plates were incubated overnight at 4°C and then
washed 20 times with phosphate buffered saline pH 7.5 + 0.05%
(vol/vol) Tween 20 (PBS-tween). Samples and standards appro-
priately diluted in CCM were then introduced, 100 4/well in
duplicate, and incubated at 37°C for three hours. Plates were
again washed 20 times with PBS-tween. The same antisera as
used for coating, but conjugated with alkaline phosphatase and
diluted 1/7000, 1/5000 and 1/10,000 respectively in PBS-tween,
were then added, 100 j.d/well as appropriate. Incubation at 37°C
was continued for a further two hours and the washing re-
peated. Substrate, paranitrophenol phosphate (Sigma Chemical
Co.) was then added, 100 jd/welI at 1 mg/mI, and plates
incubated at 37°C for a further 30 mm. Finally, the reaction was
stopped by the addition of 15 4/well of 0.25M ethylene-
diaminetetraacetic acid, and the optical densities were mea-
sured at 405 nm wavelength using a Titertek Multiskan (Flow
Laboratories). Values were determined by reference to a stan-
dard curve.
Enriched B cell and co-culture studies
Enriched populations of T and B cells were isolated from
PBMC by E-rosetting: sheep red blood cells (SRBC) were
washed three times in Dulbecco's buffer and the packed cells
resuspended in four volumes of a freshly made solution of
0. l5rt 2—aminoethylisothiouronium bromide (AET) (Calbio-
chem-Behring Australia Pty. Ltd., Kingsgrove, N.S.W., Aus-
tralia) pH 9,0. Following incubation at 37°C for 15 mm, the
SRBC were washed a further five times with Dulbecco's buffer.
To 15 ml of CCM pre-warmed to 37°C, 75 4 of packed
AET-treated SRBC and 5 x 106 to 3 x io PBMC were added,
incubated at 37°C for 15 mm, centrifuged (approximately 10 x
g for five mm) and placed on ice for 60 mm. The settled cells
were then gently resuspended and layered onto Ficoll Paque.
Following density gradient centrifugation the non-rosetting
enriched B cells were harvested from the interface and washed
three times with Dulbecco's buffer. SRBC were removed from
the rosetting T cell pellet by rapid distilled water lysis and the
remaining T cells were washed three times with Dulbecco's
buffer. Enriched T cell populations contained greater than 90%
E-rosetting cells, less than 3% Ig-bearing cells and did not
generate detectable quantities of Ig in culture. Populations of
enriched B cells contained greater than 80% Ig-bearing cells and
less than 20% E-rosetting cells. No increment in IgA synthesis
was observed when enriched B cells from control subjects were
stimulated with PWM.
Both T and B cell preparations were resuspended in CCM at
a concentration of 1 x 106 cells/ml. For co-culture, 5 x i0 of
each cell type were mixed. When T or B cells were cultured
alone, 1 ml containing 5 x l0 cells was used. No mitogens were
introduced. Ig concentrations of culture supernatants were
determined by ELISA after incubation for eight days. Co-
culture permutations fell into six groups as follows:
1. Control B cells + autologous T cells.
2. Control B cells + allogeneic control T cells.
3. Control B cells + patient T cells.
4. Patient B cells + autologous T cells.
5. Patient B cells + allogeneic patient T cells.
6. Patient B cells + control T cells.
Effect of the presence of serum on numbers of IgA producing
cells generated in culture
Duplicate 1 ml quantities of CCM containing 1 x 106 PBMC
from patients or controls were cultured without serum and in
the presence of 10% autologous, allogeneic control or al-
logeneic patient serum. No mitogens were introduced. Cells
were harvested after incubation for six days and numbers of
IgA producing cells determined by a protein A hemolytic plaque
assay, modified from that described by Lanzavecchia et al [15].
Briefly, cells were washed four times with cold Dulbecco's
buffer, resuspended in 200 4 of cold Hank's balanced salt
solution (HBSS) and kept on ice. SRBC were freshly coated
with staphylococcal protein A (Pharmacia Fine Chemicals,
Uppsala, Sweden) using chromic chloride. After three washes
with normal saline the packed protein A-coated SRBC were
resuspended at 25% (vol/vol) in HBSS. Agarose type C
(Calbiochem-Bebring Australia Pty. Ltd., Kingsgrove, N.S.W.,
Australia) 0.5% in HBSS, containing 0.45% glucose, was held at
45°C. To 300 1.d agarose, the following reagents were added in
quick succession: 25 ,td protein A-coated SRBC, 100 jsl cell
suspension, 25 4 rabbit anti-human IgA (Dako-immunoglo-
bulins, Copenhagen, Denmark) diluted 1/40 in HBSS and 25 4
guinea-pig complement (Flow Laboratories) absorbed with
SRBC and diluted 1/2 in HBSS. The mixture was vortexed and
quickly spread to form a circular monolayer in a plastic petri
dish. Plates were incubated in a humid atmosphere at 37°C for
six hours and then stored overnight at 4°C. Plaques were
scored, the results of duplicates were averaged and the data
expressed as:
Number of plaques/b6 cells cultured in the presence of serum
Number of plaques/106 cells cultured in the absence of serum
In cases where serum from one individual was cultured with
cells from more than one patient, or more than one control, an
average effect was calculated.
Serum IgA concentrations. These were determined by laser
nephelometry (Hyland, Division, Travenol Laboratories, Inc.,
Costa Mesa, California, USA).
Autolymphocytotoxic antibodies. Auto-cross-matching of se-
rum against the patient's separated T and B cells was performed
by a standard microlymphocytotoxicity test by the Red Cross
Blood Transfusion Service Reference Laboratory, Adelaide,
Australia.
Statistical analysis. With the exception of Figures 3 and 6,
mean and 5EM were used in graphic displays of data. Signifi-
cance (P) values were derived from analysis using the Mann-
Whitney U test. Critical values for correlation coefficients were
consulted to obtain the P values quoted for correlations.
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Results
Ig synthesis by PBMC
Figure 1 summarizes the data obtained from 21 patients and
21 age/sex matched controls. In unstimulated cultures, patients'
PBMC synthesized significantly larger quantities of IgA, IgG
and 1gM than those of controls. PWM stimulated synthesis of
all three Ig classes was also significantly elevated in patients.
Con A-induced suppression of PWM-stimulated Ig synthesis
resulted in the generation of similar quantities of Ig by both
patients and controls.
When the data were expressed as the PWM stimulation index
and percentage Con A suppression (Fig. 2) a different picture
was revealed. No significant differences between patients and
controls were observed for PWM stimulation index, suggesting
that the increased PWM stimulated synthesis of Ig demon-
strated for patients in Figure 1 may reflect an amplification of
the elevated unstimulated level rather than augmentation of
helper T cell activity. The percentage Con A suppression was
significantly higher in patients compared with controls in re-
spect of all three Ig classes.
Longitudinal studies of IgA synthesis by PBMC. Evaluation
of spontaneous IgA synthesis by PBMC from four patients
during periods of clinical activity and quiescence revealed an
inconsistent pattern (Fig. 3A). Marked fluctuations were ob-
served in three of the four with only one patient exhibiting high
spontaneous IgA synthesis during a clinically active episode.
Fluctuations of similar magnitude were noted for six out of eight
Fig. 3. Spontaneous synthesis of IgA by PBMC. A Patients studied
during periods of clinical activity (A) and quiescence (Q), B Patients
studied on more than one occasion while clinically inactive, C repeated
tests on control subjects. The broken line indicates the upper limit of
normal (Mean + 2 SD of 21 controls).
patients who were studied on two occasions while clinically
inactive (Fig. 3B). Differences between repeated observations
in nine control subjects (Fig. 3C) were less marked.
IgA synthesis by PBMC of first degree relatives of patients
with IgA nephropathy. The following data, expressed in ng/106
cells (Mean SEM), were obtained for synthesis of IgA by
PBMC from relatives (N = 9): unstimulated, 220 54; PWM
stimulated, 2083 634; PWM and Con A stimulated, 205 65.
A mean SEM of 17.6 5.9 was obtained for the PWM
stimulation index and 34.7 50.0 for the percentage Con A
suppression. Analysis using the Mann-Whitney U test revealed
no significant differences between these data and those indi-
cated for controls (N = 21) in Figures 1 and 2.
Ig synthesis by enriched B cells. The data obtained from
cultures of enriched B cells from eight patients and 11 controls
are summarized in Figure 4. Compared with controls, enriched
B cells of patients demonstrated a strikingly high capacity to
produce IgA. This difference was not observed for synthesis by
enriched B cells of IgG or 1gM.
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Co-culture studies
T cells from one out of seven patients markedly increased
production of IgA, IgG and 1gM by B cells from two of two
controls, perhaps indicating enhanced helper T cell activity in
that patient. However, overall analysis of the influence of
autologous, allogeneic or patient T cells on Ig synthesis by
normal B cells (Fig. 5), showed no significant differences.
Synthesis of all three Ig classes by B cells from another patient
was markedly decreased by T cells from two of two controls,
perhaps indicating failure of suppressor T cell activity in that
patient. Again, in overall analysis, no significant differences
were observed between the influences of autologous, allogeneic
patient or control T cells on lg synthesis by patient B cells (data
not shown).
Serum studies
Serum IgA concentrations were elevated in patients (N =21);
3.31 0.25 gfliter (Mean SuM) compared with controls (N =
21); 1.80 0.18 (P < 0.001) but there was no correlation
between serum IgA concentrations and spontaneous in vitro
synthesis by PBMC (R = 0.17, F> 0.2). However, as shown in
Figure 6, a significant correlation was observed between serum
IgA concentrations and spontaneous in vitro IgA synthesis by
enriched B cells (R = 0.77, P C 0.05). Serum IgA concentra-
Fig. 5. Influence ofvarious T cellpopulations on Ig synthesis by normal
B cells. *, number of T cell donors; E, Autologous T cells; IZ3,
Allogeneic T cells; Ill, Patient T cells.
tions of the nine first degree relatives of patients; 1.74 0.23
g/liter (Mean suM) did not differ significantly from those of
controls.
Tests for serum autolymphocytotoxic antibodies were nega-
tive in all of 20 patients studied.
The results of the study of the effects of sera on numbers of
IgA producing cells generated in culture of PBMC are summa-
rized in Figure 7. The presence of serum in cultures produced a
four to fivefold increment in numbers of IgA plaque forming
cells, although no significant differences were revealed between
the effects of autologous, allogeneic control or allogeneic pa-
tient sera on numbers of IgA producing cells generated in
cultures of PBMC from either controls or patients. The reason
for the observed increment in IgA plaque forming cells in the
presence of serum is not known, but the effect was not
diminished by prior heating of the sera at 56°C for 30 mm.
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Fig. 4. Spontaneous Ig synthesis by enriched B cells: comparison of
patients with IgA nephropathy and controls. E Patients (N = 8);
Controls (N = 11).
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Fig. 6. Correlation of serum IgA concentrations (giliter) with sponta-
neous IgA synthesis by enriched B cells (ng/5 X JfP cells) of patients
with IgA nephropathy. R = 0.77, P C 0.05.
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Discussion
High spontaneous in vitro synthesis of IgA and IgG by PBMC
was reported by Bannister et a! [4] in a study of ten patients
with IgA nephropathy. The present study of 21 patients con-
firms that finding and adds 1gM to the classes of Ig spontane-
ously over-produced. These data suggest that patients with IgA
nephropathy exhibit a generalized hyperimmunity.
Egido et al [5] did not find increased spontaneous synthesis of
IgA by PBMC of patients with IgA nephropathy, but reported a
significant increase, compared with controls, following PWM
stimulation. Although, in the present study, PWM stimulated
IgA synthesis was elevated in patients compared with controls,
the PWM stimulation indices were not significantly different,
suggesting that the increased PWM stimulated IgA synthesis
demonstrated for patients may reflect an amplification of the
elevated unstimulated level rather than enhanced helper T cell
activity. Egido et alES] found no difference between patients
and controls in respect of IgG and 1gM synthesis. Our data
indicate that patterns of synthesis of IgG and 1gM resemble that
observed for lgA.
Our findings are also at variance with those of Rothschild and
Chatenoud [7] who did not find exaggerated spontaneous or
PWM stimulated in vitro Ig production in patients with IgA
nephropathy. Direct comparisons between the data obtained by
those authors and ourselves are difilcult because of differences
in the techniques employed. Nontheless, some fundamental
difference in culture conditions seems likely because their
reported levels of Ig spontaneously synthesized by unfraction-
ated PBMC from control subjects were, on the whole, very
much higher than ours while, for the same subjects, their
reported increments in Ig synthesis following PWM stimulation
were, in general, considerably lower thaQ ours. The only
outstanding difference between the two patient groups studied
was the sex distribution (9:9 for the patients investigated by
Rothschild and Chatenoud) and, although this difference is
unlikely to be relevant to the present disparity of findings in
immunoregulation, it should be noted that data from different
series of patients may not always be compared.
The percentage suppression by Con A of PWM stimulated Ig
synthesis was significantly elevated in patients compared with
controls in respect of all three Ig classes. This finding, together
with the results from our T/B co-culture studies, argues against
the proposal that the increase in Ig(A) production in IgA
nephropathy is due to a decrease in suppressor T cell activity
[8].
The demonstration of an IgA-specific B cell hyperactivity in
patients with IgA nephropathy is a novel finding and the
apparent correlation between spontaneous in vitro IgA synthe-
sis by B cells and serum IgA concentrations strengthens the
possibility that B cell hyperactivity plays a role in the patho-
genesis of this disorder. In the light of the polyclonal hypenm-
munity evidenced by our data from unfractionated PB MC, it is
not clear why increased Ig synthesis by enriched B cells should
be restricted to the IgA class. Nevertheless, in a disease
characterized by deposits, predominantly of IgA in the renal
mesangium, this selective increase in IgA synthesis by enriched
B cells appears to be a potentially important finding. It is
tempting to speculate that antigen preactivation of B cells in
vivo may be more intense for IgA producing cells because the
antigens are encountered at mucosal surfaces. High levels of
unstimulated IgA (and IgG) synthesis by enriched B cells have
been reported also in patients with HSP and systemic lupus
erythematosus [16]. It has been suggested by several investiga-
tors [17—19] that IgA nephropathy represents a monosympto-
matic form of HSP. This may be true, but in respect of
immunoregulation, a difference has been observed which may
be relevant to consideration of the etiology of these disorders.
Beale et al [20] demonstrated that PBMC from patients with
HSP spontaneously synthesize increased amounts of IgA, IgG
and 1gM, however, in response to PWM stimulation, PBMC
from these patients exhibited a marked decline in synthesis of
all three Ig classes. The present study indicates that PBMC
from patients with IgA nephropathy respond to PWM stimula-
tion with a marked increase in Ig synthesis, resulting in PWM
stimulation indices which are not signficantly different from
those of control subjects.
We found no correlation between IgA synthesis by PBMC
and clinical disease activity; while marked fluctuations in IgA
synthesizing capacity were observed in three out of four pa-
tients, only one exhibited high spontaneous IgA synthesis
during an episode of clinical activity, and similar fluctuations
were noted for six of eight patients who were studied on two
occasions while clinically inactive. In HSP, longitudinal studies
by Beale et al [20] also failed to establish a correlation between
raised in vitro Ig synthesis and disease activity. However,
Feehally Ct al [21], indicated the existence of such a relationship
in some patients with IgA nephropathy. It may be worthy of
note that they studied a group of 15 patients ranging in age from
10 to 33 years (mean 16.5). In studying such comparatively
young patients, these authors may have inadvertently selected
a more homogeneous group in which clinical activity and
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Fig. 7. Effect of the presence of serum on numbers of IgA producing
cells generated in cultures of PBMC. Symbols are: *, number of scm
tested; 0, autologus scm; , allogeneic control scm; Ii, allogeneic
patient scm.
Control cells Patient cells
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immunoregulatory abnormalities are for some reason more
consistently related.
It is not known if the abnormalities in immunoregulation
described above are primary or secondary. Autolymphocyto-
toxic antibodies were detected in none of our patients and, in
contrast to the suggestion by Egido et al [5] that sera from
patients with IgA nephropathy may induce an increase in IgA
synthesis by PBMC, this study revealed no differential effect of
patient sera, in comparison with autologous or allogeneic con-
trol sera, on numbers of IgA producing cells generated in
unstimulated cultures of PBMC from patients or controls.
Instances of familial IgA nephropathy [22], tissue typing data
[23, 24] racial differences in prevalence [251 and a report of
increased numbers of IgA-bearing cells in relatives [26], all
support the possibility that genetic predisposition plays a role in
this disorder. The present study, however, found no significant
differences between first degree relatives and controls in re-
spect of spontaneous or mitogen stimulated synthesis of IgA.
In conclusion, we have shown that patients with IgA
nephropathy display a generalized hyperimmunity and, more
importantly, an IgA-specific B cell hyperactivity which appears
to correlate with the elevated serum IgA concentrations ob-
served in these patients. However, these parameters are neither
diagnostic nor of value in monitoring disease activity, limita-
tions that may reflect the possible heterogeneity of the disease
or the use of peripheral blood rather than mucosally derived
cells for study [27, 28].
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